000 | 01897 a2200517 4500 | ||
---|---|---|---|
005 | 20250515123122.0 | ||
264 | 0 | _c20080717 | |
008 | 200807s 0 0 eng d | ||
022 | _a1873-4995 | ||
024 | 7 |
_a10.1016/j.jconrel.2008.04.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHwang, S M | |
245 | 0 | 0 |
_aDelivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis. _h[electronic resource] |
260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cJul 2008 |
||
300 |
_a100-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAerosols |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 |
_aHyaluronic Acid _xchemistry |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aLactose _xchemistry |
650 | 0 | 4 |
_aLung _xmetabolism |
650 | 0 | 4 |
_aMacrophages, Alveolar _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicrospheres |
650 | 0 | 4 | _aNebulizers and Vaporizers |
650 | 0 | 4 |
_aOfloxacin _xadministration & dosage |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 | _aTissue Distribution |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aKim, D D | |
700 | 1 | _aChung, S J | |
700 | 1 | _aShim, C K | |
773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 129 _gno. 2 _gp. 100-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2008.04.009 _zAvailable from publisher's website |
999 |
_c18024257 _d18024257 |